The Development and Content Validation of the Sjögren’s Related Quality of Life Instrument (SRQoL)
The SRQoL is a new PRO instrument to assess Sjögren's impact on HRQoL, developed in accordance with regulatory guidance. This study provides considerable insight into the patient experience of Sjögren's and evidence to support the content validity of the SRQoL. Future research should evaluate the psychometric properties of the SRQoL to support its use in clinical trials and clinical practice and further validate its use as an assessment of treatment benefit.
Authors
- Gayle Kenney
- Jessica Marvel (ORCID: https://orcid.org/0000-0002-0757-5865)
- Pushpendra Goswami (ORCID: https://orcid.org/0000-0002-3171-2495)
- Chloe Howse
- Monia Steenackers
- Elizabeth Gargon (ORCID: https://orcid.org/0000-0002-3848-0113)
- Nicola Williamson (ORCID: https://orcid.org/0000-0002-9717-8563)
- Linda Stone (ORCID: https://orcid.org/0000-0002-7304-4843)
- Chiara Perella
- Megan Mayhew
- Benjamin A. Fisher
- Aishwarya Chohan
Institutions
- Novartis (Switzerland) (CH)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- National Institute for Health and Care Research (GB)
- Adelphi Group (United Kingdom) (GB)
- British Sjögren's Syndrome Association (GB)
- NIHR Birmingham Biomedical Research Centre (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1007/s40744-024-00718-6
- Citations
- 4
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Novartis